HERON THERAPEUTICS, INC. /DE/ (HRTX)

SEC filing

HERON THERAPEUTICS, INC. /DE/

HRTX · CIK 818033

4 · Oct 21, 2026 · Director, Chief Executive Officer Collard Craig A exercised options for 27.59K shares; reported 3,360 shares

Director, Chief Executive Officer Collard Craig A exercised options for 27.59K shares; reported 3,360 shares

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).